Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

NCT05966025 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Fatty Liver Disease
Fatty Liver

Interventions

DRUG: Itopride
DRUG: conventional therapy

Sponsor

October 6 University

Collaborators

[object Object]